Diagnostic accuracy of urine dipstick testing in screening for microalbuminuria in type 2 diabetes: A cohort study in primary care

Family Practice

Volumn 30, Issue 2, 2013, Pages 142-152

  Nagrebetsky, Alexander ^a,b   Jin, Jing ^a,b   Stevens, Richard ^a,b   James, Timothy ^c   Adler, Amanda ^d   Park, Paul ^e   Craven, Anthea ^a,b   Shine, Brian ^c   Farmer, Andrew ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b University of Manchester   (United Kingdom)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e Banbury Health Centre   (United Kingdom)

Author keywords

Albuminuria; Point of care system; Sensitivity and specificity; Type 2 diabetes mellitus

Indexed keywords

AGE DISTRIBUTION; AGED; ALBUMIN CREATININE RATIO; ARTICLE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; GENERAL PRACTICE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; UNITED KINGDOM; URINE DIPSTICK TESTING; UROGENITAL SYSTEM PARAMETERS; UROLOGIC EXAMINATION;

AGED; AGED, 80 AND OVER; ALBUMINURIA; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; PREVALENCE; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; REAGENT STRIPS; SENSITIVITY AND SPECIFICITY;

EID: 84875636022     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cms057     Document Type: Article

References (20)

1. Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-6.
2. National Collaborating Centre for Chronic Conditions. Type 2 Diabetes: National Clinical Guideline for Management in Primary and Secondary Care (Update). London: Royal College of Physicians, 2008.
3. American Diabetes Association. Standards of medical care in diabetes - 2012. Diabetes Care 2012; 35 (suppl 1): S11-63.
4. Sacks DB, Arnold M, Bakris GL et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011; 57: e1-47.
5. Kuritzky L, Toto R, Van Buren P. Identification and management of albuminuria in the primary care setting. J Clin Hypertens (Greenwich) 2011; 13: 438-49.
6. Albuminuria. Johns Hopkins Diabetes Guide. http://www.hopkinsguides.com/hopkins/ub/view/Johns_Hopkins_Diabetes_Guide/547004/all/Albuminuria (accessed on 16 March 2012).
7. Chadban S, Howell M, Twigg S, et al. National Evidence Based Guideline for Diagnosis, Prevention and Management of Chronic Kidney Disease in Type 2 Diabetes. Canberra: Diabetes Australia and the NHMRC, 2009.
8. Scheid DC, McCarthy LH, Lawler FH, Hamm RM, Reilly KE. Screening for microalbuminuria to prevent nephropathy in patients with diabetes: a systematic review of the evidence. J Fam Pract 2001; 50: 661-8.
9. The DCCT Research Group. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. Diabetes 1986; 35: 530-45.
10. Comper WD, Jerums G, Osicka TM. Deficiency in the detection of microalbuminuria by urinary dipstick in diabetic patients. Diabetes Care 2003; 26: 3195-6.
11. Incerti J, Zelmanovitz T, Camargo JL, Gross JL, de Azevedo MJ. Evaluation of tests for microalbuminuria screening in patients with diabetes. Nephrol Dial Transplant 2005; 20: 2402-7.
12. Sarafidis PA, Riehle J, Bogojevic Z et al. A comparative evaluation of various methods for microalbuminuria screening. Am J Nephrol 2008; 28: 324-9.
13. Mogensen CE, Viberti GC, Peheim E et al. Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care 1997; 20: 1642-6.
14. Lepore G, Maglio ML, Nosari I, Dodesini AR, Trevisan R. Cost-effectiveness of two screening programs for microalbuminuria in type 2 diabetes. Diabetes Care 2002; 25: 2103-4; author reply 2104.
15. Szymanowicz A, Blanc-Bernard E, Roche C et al. Évaluation du Micral Test® en vue du dépistage de la microalbuminurie en biologie dÉlocalisÉe. Immuno-analyse & Biologie SpÉcialisÉe 2008; 23: 109-115.
16. Davidson MB, Bazargan M, Bakris G et al. ImmunoDip: an improved screening method for microalbuminuria. Am J Nephrol 2004; 24: 284-8.
17. Pugia MJ, Lott JA, Luke KE et al. Comparison of instrument-read dipsticks for albumin and creatinine in urine with visual results and quantitative methods. J Clin Lab Anal 1998; 12: 280-4.
18. Pearson S, Lamph S, Bennitt W, Halloran SP. Buyer's Guide: Point of Care Devices for the Measurement of HbA1c and Low Concentration Albumin in Urine. London: NHS Purchasing and Supply Agency. Centre for Evidence-based Purchasing, 2009.
19. Ewald B, Attia J. Which test to detect microalbuminuria in diabetic patients? A systematic review. Aust Fam Physician 2004; 33: 565-7, 571.
20. Lambers Heerspink HJ, Brantsma AH, de Zeeuw D et al. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 2008; 168: 897-905.